Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 314 entries
Sorted by: Best Match Show Resources per page
Rare use of robotic surgery for removal of large urachal carcinoma.

Journal of robotic surgery

Kosanovic R, Romero RJ, Arad JK, Gallas M, Seetharamaiah R, Gonzalez AM.
PMID: 27637529
J Robot Surg. 2014 Jun;8(2):177-80. doi: 10.1007/s11701-013-0415-2. Epub 2013 Jun 11.

Minimally invasive surgery has been used traditionally for removal of colorectal, gastric and gallbladder disease pathologies with great success. Many advantages have been demonstrated with the addition of robotic surgery, such as 3-D visualization, articulation of instruments and improved...

Cite
Kosanovic R, Romero RJ, Arad JK, et al. Rare use of robotic surgery for removal of large urachal carcinoma. J Robot Surg. 2013;8(2):177-80doi: 10.1007/s11701-013-0415-2.
Kosanovic, R., Romero, R. J., Arad, J. K., Gallas, M., Seetharamaiah, R., & Gonzalez, A. M. (2014). Rare use of robotic surgery for removal of large urachal carcinoma. Journal of robotic surgery, 8(2), 177-80. https://doi.org/10.1007/s11701-013-0415-2
Kosanovic, Radomir, et al. "Rare use of robotic surgery for removal of large urachal carcinoma." Journal of robotic surgery vol. 8,2 (2014): 177-80. doi: https://doi.org/10.1007/s11701-013-0415-2
Kosanovic R, Romero RJ, Arad JK, Gallas M, Seetharamaiah R, Gonzalez AM. Rare use of robotic surgery for removal of large urachal carcinoma. J Robot Surg. 2014 Jun;8(2):177-80. doi: 10.1007/s11701-013-0415-2. Epub 2013 Jun 11. PMID: 27637529.
Copy Download .nbib Format: NLM
Solvation Thermodynamic Properties of Hydrogen Sulfide in [C4mim][PF6], [C4mim][BF4], and [C4mim][Cl] Ionic Liquids, Determined by Molecular Simulations.

The journal of physical chemistry. B

Sánchez-Badillo J, Gallo M, Alvarado S, Glossman-Mitnik D.
PMID: 26237624
J Phys Chem B. 2015 Aug 20;119(33):10727-37. doi: 10.1021/acs.jpcb.5b06525. Epub 2015 Aug 10.

Removal of hydrogen sulfide (H2S) and acid gases from natural gas is accomplished by absorption processes using a solvent. The gas solubility in a liquid can be used to measure the degree of removal of the gas and is...

Cite
Sánchez-Badillo J, Gallo M, Alvarado S, et al. Solvation Thermodynamic Properties of Hydrogen Sulfide in [C4mim][PF6], [C4mim][BF4], and [C4mim][Cl] Ionic Liquids, Determined by Molecular Simulations. J Phys Chem B. 2015;119(33):10727-37doi: 10.1021/acs.jpcb.5b06525.
Sánchez-Badillo, J., Gallo, M., Alvarado, S., & Glossman-Mitnik, D. (2015). Solvation Thermodynamic Properties of Hydrogen Sulfide in [C4mim][PF6], [C4mim][BF4], and [C4mim][Cl] Ionic Liquids, Determined by Molecular Simulations. The journal of physical chemistry. B, 119(33), 10727-37. https://doi.org/10.1021/acs.jpcb.5b06525
Sánchez-Badillo, Joel, et al. "Solvation Thermodynamic Properties of Hydrogen Sulfide in [C4mim][PF6], [C4mim][BF4], and [C4mim][Cl] Ionic Liquids, Determined by Molecular Simulations." The journal of physical chemistry. B vol. 119,33 (2015): 10727-37. doi: https://doi.org/10.1021/acs.jpcb.5b06525
Sánchez-Badillo J, Gallo M, Alvarado S, Glossman-Mitnik D. Solvation Thermodynamic Properties of Hydrogen Sulfide in [C4mim][PF6], [C4mim][BF4], and [C4mim][Cl] Ionic Liquids, Determined by Molecular Simulations. J Phys Chem B. 2015 Aug 20;119(33):10727-37. doi: 10.1021/acs.jpcb.5b06525. Epub 2015 Aug 10. PMID: 26237624.
Copy Download .nbib Format: NLM
Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management.

Frontiers in immunology

Perez E, Bonilla FA, Orange JS, Ballow M.
PMID: 29576764
Front Immunol. 2018 Mar 15;9:450. doi: 10.3389/fimmu.2018.00450. eCollection 2018.

[This corrects the article on p. 586 in vol. 8, PMID: 28588580.].

Cite
Perez E, Bonilla FA, Orange JS, et al. Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management. Front Immunol. 2018;9:450doi: 10.3389/fimmu.2018.00450.
Perez, E., Bonilla, F. A., Orange, J. S., & Ballow, M. (2018). Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management. Frontiers in immunology, 9450. https://doi.org/10.3389/fimmu.2018.00450
Perez, Elena, et al. "Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management." Frontiers in immunology vol. 9 (2018): 450. doi: https://doi.org/10.3389/fimmu.2018.00450
Perez E, Bonilla FA, Orange JS, Ballow M. Corrigendum: Specific Antibody Deficiency: Controversies in Diagnosis and Management. Front Immunol. 2018 Mar 15;9:450. doi: 10.3389/fimmu.2018.00450. eCollection 2018. PMID: 29576764; PMCID: PMC5863213.
Copy Download .nbib Format: NLM
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.

International journal of endocrinology

Catalano MG, Pugliese M, Gallo M, Brignardello E, Milla P, Orlandi F, Limone PP, Arvat E, Boccuzzi G, Piovesan A.
PMID: 27766105
Int J Endocrinol. 2016;2016:2930414. doi: 10.1155/2016/2930414. Epub 2016 Sep 27.

Anaplastic thyroid cancer (ATC) has a median survival less than 5 months and, to date, no effective therapy exists. Taxanes have recently been stated as the main drug treatment for ATC, and the histone deacetylase inhibitor valproic acid efficiently...

Cite
Catalano MG, Pugliese M, Gallo M, et al. Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. Int J Endocrinol. 2016;2016:2930414doi: 10.1155/2016/2930414.
Catalano, M. G., Pugliese, M., Gallo, M., Brignardello, E., Milla, P., Orlandi, F., Limone, P. P., Arvat, E., Boccuzzi, G., & Piovesan, A. (2016). Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. International journal of endocrinology, 20162930414. https://doi.org/10.1155/2016/2930414
Catalano, Maria Graziella, et al. "Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial." International journal of endocrinology vol. 2016 (2016): 2930414. doi: https://doi.org/10.1155/2016/2930414
Catalano MG, Pugliese M, Gallo M, Brignardello E, Milla P, Orlandi F, Limone PP, Arvat E, Boccuzzi G, Piovesan A. Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial. Int J Endocrinol. 2016;2016:2930414. doi: 10.1155/2016/2930414. Epub 2016 Sep 27. PMID: 27766105; PMCID: PMC5059567.
Copy Download .nbib Format: NLM
Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Frontiers in immunology

Agallou M, Athanasiou E, Koutsoni O, Dotsika E, Karagouni E.
PMID: 24959167
Front Immunol. 2014 Jun 10;5:268. doi: 10.3389/fimmu.2014.00268. eCollection 2014.

Leishmaniasis is a significant worldwide health problem for which no vaccine exists. Activation of CD4(+) and CD8(+) T cells is crucial for the generation of protective immunity against parasite. Recent trend in vaccine design has been shifted to epitope-based...

Cite
Agallou M, Athanasiou E, Koutsoni O, et al. Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins. Front Immunol. 2014;5:268doi: 10.3389/fimmu.2014.00268.
Agallou, M., Athanasiou, E., Koutsoni, O., Dotsika, E., & Karagouni, E. (2014). Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins. Frontiers in immunology, 5268. https://doi.org/10.3389/fimmu.2014.00268
Agallou, Maria, et al. "Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins." Frontiers in immunology vol. 5 (2014): 268. doi: https://doi.org/10.3389/fimmu.2014.00268
Agallou M, Athanasiou E, Koutsoni O, Dotsika E, Karagouni E. Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins. Front Immunol. 2014 Jun 10;5:268. doi: 10.3389/fimmu.2014.00268. eCollection 2014. PMID: 24959167; PMCID: PMC4051127.
Copy Download .nbib Format: NLM
Surgical implantation of the CardioWest Total Artificial Heart.

Annals of cardiothoracic surgery

Tarzia V, Buratto E, Gallo M, Bortolussi G, Bejko J, Dal Lin C, Torregrossa G, Bianco R, Bottio T, Gerosa G.
PMID: 25512906
Ann Cardiothorac Surg. 2014 Nov;3(6):624-5. doi: 10.3978/j.issn.2225-319X.2014.08.16.

No abstract available.

Cite
Tarzia V, Buratto E, Gallo M, et al. Surgical implantation of the CardioWest Total Artificial Heart. Ann Cardiothorac Surg. 2014;3(6):624-5doi: 10.3978/j.issn.2225-319X.2014.08.16.
Tarzia, V., Buratto, E., Gallo, M., Bortolussi, G., Bejko, J., Dal Lin, C., Torregrossa, G., Bianco, R., Bottio, T., & Gerosa, G. (2014). Surgical implantation of the CardioWest Total Artificial Heart. Annals of cardiothoracic surgery, 3(6), 624-5. https://doi.org/10.3978/j.issn.2225-319X.2014.08.16
Tarzia, Vincenzo, et al. "Surgical implantation of the CardioWest Total Artificial Heart." Annals of cardiothoracic surgery vol. 3,6 (2014): 624-5. doi: https://doi.org/10.3978/j.issn.2225-319X.2014.08.16
Tarzia V, Buratto E, Gallo M, Bortolussi G, Bejko J, Dal Lin C, Torregrossa G, Bianco R, Bottio T, Gerosa G. Surgical implantation of the CardioWest Total Artificial Heart. Ann Cardiothorac Surg. 2014 Nov;3(6):624-5. doi: 10.3978/j.issn.2225-319X.2014.08.16. PMID: 25512906; PMCID: PMC4250547.
Copy Download .nbib Format: NLM
Human papillomavirus prevalence to age 60 years among Australian women prevaccination.

Sexual health

Brotherton JM, Condon JR, McIntyre PB, Tabrizi SN, Malloy M, Garland SM, Whinurs Study Group OB.
PMID: 26027443
Sex Health. 2015 Aug;12(4):353-9. doi: 10.1071/SH15035.

UNLABELLED: Background The prevalence of human papillomavirus (HPV) at the cervix varies with age, peaking following sexual debut and declining thereafter in most populations. In some populations, a second peak is observed. Here we describe the prevalence of HPV...

Cite
Brotherton JM, Condon JR, McIntyre PB, et al. Human papillomavirus prevalence to age 60 years among Australian women prevaccination. Sex Health. 2015;12(4):353-9doi: 10.1071/SH15035.
Brotherton, J. M., Condon, J. R., McIntyre, P. B., Tabrizi, S. N., Malloy, M., Garland, S. M., & Whinurs Study Group, O. B. (2015). Human papillomavirus prevalence to age 60 years among Australian women prevaccination. Sexual health, 12(4), 353-9. https://doi.org/10.1071/SH15035
Brotherton, Julia M L, et al. "Human papillomavirus prevalence to age 60 years among Australian women prevaccination." Sexual health vol. 12,4 (2015): 353-9. doi: https://doi.org/10.1071/SH15035
Brotherton JM, Condon JR, McIntyre PB, Tabrizi SN, Malloy M, Garland SM, Whinurs Study Group OB. Human papillomavirus prevalence to age 60 years among Australian women prevaccination. Sex Health. 2015 Aug;12(4):353-9. doi: 10.1071/SH15035. PMID: 26027443.
Copy Download .nbib Format: NLM
Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points.

Case reports in gastrointestinal medicine

López-Medina G, Gallo M, Prado A, Vicuña-Honorato I, Castillo Díaz de León R.
PMID: 26075112
Case Rep Gastrointest Med. 2015;2015:239506. doi: 10.1155/2015/239506. Epub 2015 May 05.

Eosinophilic gastroenteritis is considered an uncommon disease with a low incidence rate that remains as a diagnostic challenge for the clinician, in spite of the fact that seventy years have passed since its original description. Hereby we present the...

Cite
López-Medina G, Gallo M, Prado A, et al. Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points. Case Rep Gastrointest Med. 2015;2015:239506doi: 10.1155/2015/239506.
López-Medina, G., Gallo, M., Prado, A., Vicuña-Honorato, I., & Castillo Díaz de León, R. (2015). Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points. Case reports in gastrointestinal medicine, 2015239506. https://doi.org/10.1155/2015/239506
López-Medina, Guillermo, et al. "Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points." Case reports in gastrointestinal medicine vol. 2015 (2015): 239506. doi: https://doi.org/10.1155/2015/239506
López-Medina G, Gallo M, Prado A, Vicuña-Honorato I, Castillo Díaz de León R. Eosinophilic Gastroenteritis: Case Report and Review in Search for Diagnostic Key Points. Case Rep Gastrointest Med. 2015;2015:239506. doi: 10.1155/2015/239506. Epub 2015 May 05. PMID: 26075112; PMCID: PMC4436468.
Copy Download .nbib Format: NLM
TWOC around the clock: a multimodal approach to improving catheter care.

Journal of infection prevention

Dawson CH, Gallo M, Prevc K.
PMID: 28989506
J Infect Prev. 2017 Mar;18(2):57-64. doi: 10.1177/1757177416668584. Epub 2016 Nov 01.

BACKGROUND: Urinary tract infections (UTI) are the second-largest group of healthcare-associated infections (HCAI). The Saving Lives Urinary Catheter Care Bundle was introduced to reduce catheter-associated urinary tract infections (CAUTI). In response, we implemented a catheter care group to examine...

Cite
Dawson CH, Gallo M, Prevc K. TWOC around the clock: a multimodal approach to improving catheter care. J Infect Prev. 2016;18(2):57-64doi: 10.1177/1757177416668584.
Dawson, C. H., Gallo, M., & Prevc, K. (2017). TWOC around the clock: a multimodal approach to improving catheter care. Journal of infection prevention, 18(2), 57-64. https://doi.org/10.1177/1757177416668584
Dawson, Carolyn H, et al. "TWOC around the clock: a multimodal approach to improving catheter care." Journal of infection prevention vol. 18,2 (2017): 57-64. doi: https://doi.org/10.1177/1757177416668584
Dawson CH, Gallo M, Prevc K. TWOC around the clock: a multimodal approach to improving catheter care. J Infect Prev. 2017 Mar;18(2):57-64. doi: 10.1177/1757177416668584. Epub 2016 Nov 01. PMID: 28989506; PMCID: PMC5360203.
Copy Download .nbib Format: NLM
Total Absorption Spectroscopy Study of (92)Rb Decay: A Major Contributor to Reactor Antineutrino Spectrum Shape.

Physical review letters

Zakari-Issoufou AA, Fallot M, Porta A, Algora A, Tain JL, Valencia E, Rice S, Bui VM, Cormon S, Estienne M, Agramunt J, Äystö J, Bowry M, Briz JA, Caballero-Folch R, Cano-Ott D, Cucoanes A, Elomaa VV, Eronen T, Estévez E, Farrelly GF, Garcia AR, Gelletly W, Gomez-Hornillos MB, Gorlychev V, Hakala J, Jokinen A, Jordan MD, Kankainen A, Karvonen P, Kolhinen VS, Kondev FG, Martinez T, Mendoza E, Molina F, Moore I, Perez-Cerdán AB, Podolyák Z, Penttilä H, Regan PH, Reponen M, Rissanen J, Rubio B, Shiba T, Sonzogni AA, Weber C.
PMID: 26382674
Phys Rev Lett. 2015 Sep 04;115(10):102503. doi: 10.1103/PhysRevLett.115.102503. Epub 2015 Sep 04.

The antineutrino spectra measured in recent experiments at reactors are inconsistent with calculations based on the conversion of integral beta spectra recorded at the ILL reactor. (92)Rb makes the dominant contribution to the reactor antineutrino spectrum in the 5-8...

Cite
Zakari-Issoufou AA, Fallot M, Porta A, et al. Total Absorption Spectroscopy Study of (92)Rb Decay: A Major Contributor to Reactor Antineutrino Spectrum Shape. Phys Rev Lett. 2015;115(10):102503doi: 10.1103/PhysRevLett.115.102503.
Zakari-Issoufou, A. A., Fallot, M., Porta, A., Algora, A., Tain, J. L., Valencia, E., Rice, S., Bui, V. M., Cormon, S., Estienne, M., Agramunt, J., Äystö, J., Bowry, M., Briz, J. A., Caballero-Folch, R., Cano-Ott, D., Cucoanes, A., Elomaa, V. V., Eronen, T., Estévez, E., Farrelly, G. F., Garcia, A. R., Gelletly, W., Gomez-Hornillos, M. B., Gorlychev, V., Hakala, J., Jokinen, A., Jordan, M. D., Kankainen, A., Karvonen, P., Kolhinen, V. S., Kondev, F. G., Martinez, T., Mendoza, E., Molina, F., Moore, I., Perez-Cerdán, A. B., Podolyák, Z., Penttilä, H., Regan, P. H., Reponen, M., Rissanen, J., Rubio, B., Shiba, T., Sonzogni, A. A., Weber, C. (2015). Total Absorption Spectroscopy Study of (92)Rb Decay: A Major Contributor to Reactor Antineutrino Spectrum Shape. Physical review letters, 115(10), 102503. https://doi.org/10.1103/PhysRevLett.115.102503
Zakari-Issoufou, A-A, et al. "Total Absorption Spectroscopy Study of (92)Rb Decay: A Major Contributor to Reactor Antineutrino Spectrum Shape." Physical review letters vol. 115,10 (2015): 102503. doi: https://doi.org/10.1103/PhysRevLett.115.102503
Zakari-Issoufou AA, Fallot M, Porta A, Algora A, Tain JL, Valencia E, Rice S, Bui VM, Cormon S, Estienne M, Agramunt J, Äystö J, Bowry M, Briz JA, Caballero-Folch R, Cano-Ott D, Cucoanes A, Elomaa VV, Eronen T, Estévez E, Farrelly GF, Garcia AR, Gelletly W, Gomez-Hornillos MB, Gorlychev V, Hakala J, Jokinen A, Jordan MD, Kankainen A, Karvonen P, Kolhinen VS, Kondev FG, Martinez T, Mendoza E, Molina F, Moore I, Perez-Cerdán AB, Podolyák Z, Penttilä H, Regan PH, Reponen M, Rissanen J, Rubio B, Shiba T, Sonzogni AA, Weber C. Total Absorption Spectroscopy Study of (92)Rb Decay: A Major Contributor to Reactor Antineutrino Spectrum Shape. Phys Rev Lett. 2015 Sep 04;115(10):102503. doi: 10.1103/PhysRevLett.115.102503. Epub 2015 Sep 04. PMID: 26382674.
Copy Download .nbib Format: NLM
Parathyroid hormone as a marker for metabolic bone disease of prematurity.

Journal of perinatology : official journal of the California Perinatal Association

Moreira A, Swischuk L, Malloy M, Mudd D, Blanco C, Geary C.
PMID: 26219702
J Perinatol. 2015 Aug;35(8):667. doi: 10.1038/jp.2015.64.

No abstract available.

Cite
Moreira A, Swischuk L, Malloy M, et al. Parathyroid hormone as a marker for metabolic bone disease of prematurity. J Perinatol. 2015;35(8):667doi: 10.1038/jp.2015.64.
Moreira, A., Swischuk, L., Malloy, M., Mudd, D., Blanco, C., & Geary, C. (2015). Parathyroid hormone as a marker for metabolic bone disease of prematurity. Journal of perinatology : official journal of the California Perinatal Association, 35(8), 667. https://doi.org/10.1038/jp.2015.64
Moreira, A, et al. "Parathyroid hormone as a marker for metabolic bone disease of prematurity." Journal of perinatology : official journal of the California Perinatal Association vol. 35,8 (2015): 667. doi: https://doi.org/10.1038/jp.2015.64
Moreira A, Swischuk L, Malloy M, Mudd D, Blanco C, Geary C. Parathyroid hormone as a marker for metabolic bone disease of prematurity. J Perinatol. 2015 Aug;35(8):667. doi: 10.1038/jp.2015.64. PMID: 26219702.
Copy Download .nbib Format: NLM
Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis.

Pathology oncology research : POR

Kovalszky, Nagy JO, Gallai M, Sebestyén A, Schaff Z, Paku S, Jeney A, Iozzo RV.
PMID: 11173626
Pathol Oncol Res. 1997;3(1):51-58. doi: 10.1007/BF02893354.

Proteoglycans play key roles in the physiological assembly of extracellular matrices and in the modulation of growth factor activities. During liver regeneration there is a profound remodelling of the connective tissue network with a concurrent alteration in proteoglycan gene...

Cite
Kovalszky, Nagy JO, Gallai M, et al. Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis. Pathol Oncol Res. 1997;3(1):51-58doi: 10.1007/BF02893354.
Kovalszky, Nagy, J. O., Gallai, M., Sebestyén, A., Schaff, Z., Paku, S., Jeney, A., & Iozzo, R. V. (1997). Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis. Pathology oncology research : POR, 3(1), 51-58. https://doi.org/10.1007/BF02893354
Kovalszky, Ilona, et al. "Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis." Pathology oncology research : POR vol. 3,1 (1997): 51-58. doi: https://doi.org/10.1007/BF02893354
Kovalszky, Nagy JO, Gallai M, Sebestyén A, Schaff Z, Paku S, Jeney A, Iozzo RV. Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis. Pathol Oncol Res. 1997;3(1):51-58. doi: 10.1007/BF02893354. PMID: 11173626.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 314 entries